We are live on ! Find out more
SIG

Stonegate Investment Group Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.07%
This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+18.07%
3 Year Est. Return
+88.83%
5 Year Est. Return
10 Year Est. Return
AUM
$3.19B
AUM Growth
+$165M
Cap. Flow
-$71.8M
Cap. Flow %
-2.25%
Top 10 Hldgs %
40.24%
Holding
390
New
43
Increased
152
Reduced
103
Closed
23

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$37.3M
2
TSM icon
TSMC
TSM
+$9.82M
3
NEE icon
NextEra Energy
NEE
+$6.89M
4
IVE icon
iShares S&P 500 Value ETF
IVE
+$2.66M
5
WDAY icon
Workday
WDAY
+$2.54M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$61.8M
2
IBM icon
IBM
IBM
+$56.5M
3
MSFT icon
Microsoft
MSFT
+$20.3M
4
DHR icon
Danaher
DHR
+$11.5M
5
LLY icon
Eli Lilly
LLY
+$9.2M

Sector Composition

Rank Sector Weight
1 Technology 20.17%
2 Financials 14.1%
3 Healthcare 12.07%
4 Energy 10.73%
5 Consumer Staples 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKTA icon
126
Okta
OKTA
$24.7B
$1.72M 0.05%
16,408
GS icon
127
Goldman Sachs
GS
$300B
$1.71M 0.05%
4,089
+226
+6% +$87.7K
RDFN
128
DELISTED
Redfin
RDFN
$1.68M 0.05%
252,000
CCI icon
129
Crown Castle
CCI
$33.3B
$1.64M 0.05%
15,481
+1,509
+11% +$164K
BMY icon
130
Bristol-Myers Squibb
BMY
$133B
$1.55M 0.05%
28,572
+24
+0.1% +$1.22K
ECL icon
131
Ecolab
ECL
$78.1B
$1.55M 0.05%
6,697
-8
-0.1% -$1.7K
CFLT
132
DELISTED
Confluent
CFLT
$1.53M 0.05%
50,000
+9,000
+22% +$254K
APD icon
133
Air Products & Chemicals
APD
$65.7B
$1.47M 0.05%
6,071
+1,014
+20% +$248K
TEAM icon
134
Atlassian
TEAM
$25.6B
$1.44M 0.05%
7,362
+88
+1% +$19.2K
SNOW icon
135
Snowflake
SNOW
$102B
$1.43M 0.05%
8,877
-92
-1% -$17.8K
EW icon
136
Edwards Lifesciences
EW
$49.6B
$1.41M 0.04%
14,764
+1,920
+15% +$161K
ETN icon
137
Eaton
ETN
$161B
$1.41M 0.04%
4,509
-394
-8% -$108K
FIS icon
138
Fidelity National Information Services
FIS
$23.1B
$1.36M 0.04%
18,297
+956
+6% +$62.2K
FCX icon
139
Freeport-McMoran
FCX
$90B
$1.36M 0.04%
28,826
+1,661
+6% +$67.1K
DT icon
140
Dynatrace
DT
$12.9B
$1.35M 0.04%
29,070
VUG icon
141
Vanguard Morningstar Growth ETF
VUG
$225B
$1.33M 0.04%
23,178
+1,908
+9% +$105K
VRTX icon
142
Vertex Pharmaceuticals
VRTX
$121B
$1.31M 0.04%
3,144
-132
-4% -$55.8K
BDX icon
143
Becton Dickinson
BDX
$45.6B
$1.28M 0.04%
5,170
+396
+8% +$94.8K
PM icon
144
Philip Morris
PM
$297B
$1.26M 0.04%
13,716
-556
-4% -$51.3K
VO icon
145
Vanguard Morningstar Mid-Cap ETF
VO
$108B
$1.25M 0.04%
20,044
+2,468
+14% +$146K
TWLO icon
146
Twilio
TWLO
$30B
$1.23M 0.04%
20,045
IJR icon
147
iShares Core S&P Small-Cap ETF
IJR
$111B
$1.21M 0.04%
10,956
+3,575
+48% +$380K
AMD icon
148
Advanced Micro Devices
AMD
$776B
$1.21M 0.04%
6,687
-60
-0.9% -$10.5K
IWV icon
149
iShares Russell 3000 ETF
IWV
$19.9B
$1.2M 0.04%
4,006
SNAP icon
150
Snap
SNAP
$7.89B
$1.19M 0.04%
103,470

Similar funds

Stonegate Investment Group's Q1 2024 Portfolio in Review

As of Q1 2024, Stonegate Investment Group held 390 positions worth $3.19B, up 5.5% from $3.02B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Stonegate Investment Group's Q1 2024 filing shows 43 new, 152 increased, 103 reduced and 23 closed positions. Its largest new stake was TSMC: 79,064 shares worth $10.8M. The largest sale was AbbVie, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Stonegate Investment Group's largest Q1 2024 buy was TSMC: 79,064 shares worth $10.8M.
  • Stonegate Investment Group added most to Amgen in Q1 2024, an estimated $37.3M increase.
  • Stonegate Investment Group's biggest Q1 2024 reduction was AbbVie, cutting an estimated $61.8M.
  • Stonegate Investment Group fully exited Humana in Q1 2024, selling an estimated $3.28M.
  • Stonegate Investment Group's ten largest holdings make up 40% of its $3.19B portfolio in Q1 2024.
  • Stonegate Investment Group opened 43 new positions and closed 23 in Q1 2024.
  • Stonegate Investment Group's portfolio value rose 5.5% quarter-over-quarter to $3.19B.

Based on Stonegate Investment Group's 13F filing for Q1 2024, filed 22 Apr 2024.